Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
Iran, Russia Discussing Joint Production of COVID-19 Vaccine: Agencies
Error: Contact form not found.
by Reuters and Algemeiner Staff
A nurse prepares Russia’s ‘Sputnik-V’ vaccine against the coronavirus disease (COVID-19), for inoculation in a post-registration trials stage, at a clinic in Moscow, Russia, Sept. 17, 2020. Photo: Reuters / Tatyana Makeyeva.
Iran and Russia’s sovereign wealth fund are discussing the joint production of a vaccine against COVID-19, Russian news agencies cited the Iranian ambassador to Moscow as saying on Friday.
The Russian Direct Investment Fund (RDIF) has said it is in talks with a number of countries about the possibility of producing the Russian “Sputnik-V” vaccine abroad, and has signed a deal to manufacture 300 million doses in India.
“We are holding talks, I spoke with the head of RDIF Kirill Dmitriev, our officials have held several rounds of consultations and we announced that we will co-operate,” Iran’s Ambassador to Moscow Kazem Jalali was quoted as saying.
“We announced that we will co-operate in two-three areas. That includes joint production with Russia. Iran has great potential to produce the vaccine,” Jalali was quoted as saying.
RDIF declined to comment on the Iran talks. RDIF has also struck several deals in recent weeks to supply the vaccine, which is currently being tested in a large-scale trial in Moscow, abroad.
It has signed deals with Kazakhstan and two states in Brazil, and private pharmaceutical firms in India and Mexico.
RDIF also said earlier on Friday it would supply 35 million doses to Laxisam, a pharmaceutical firm in Uzbekistan.
